Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer by Konrad Sopyllo, Andrew M. Erickson, Tuomas Mirtti

Get full text

Spectral decoupling for training transferable neural networks in medical imaging by Joona Pohjonen, Carolin Stürenberg, Antti Rannikko, Tuomas Mirtti, Esa Pitkänen

Get full text

Active surveillance versus initial surgery in the long-term management of Bosniak IIF–IV cystic renal masses by Lassi Luomala, Juhana Rautiola, Petrus Järvinen, Tuomas Mirtti, Harry Nisén

Get full text

Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression. by Irena Saarinen, Tuomas Mirtti, Heikki Seikkula, Peter J Boström, Pekka Taimen

Get full text

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer by Matias Blomqvist, Ilmari Koskinen, Eliisa Löyttyniemi, Tuomas Mirtti, Peter J. Boström, Pekka Taimen

Get full text

OSCAR: Optimal subset cardinality regression using the L0-pseudonorm with applications to prognostic modelling of prostate cancer. by Anni S Halkola, Kaisa Joki, Tuomas Mirtti, Marko M Mäkelä, Tero Aittokallio, Teemu D Laajala

Get full text

Three-Dimensional Presentation of Tumor Histopathology: A Model Using Tongue Squamous Cell Carcinoma by Anne Koivuholma, Katri Aro, Antti Mäkitie, Mika Salmi, Tuomas Mirtti, Jaana Hagström, Timo Atula

Get full text

Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma. by Juhana Rautiola, Anita Lampinen, Tuomas Mirtti, Ari Ristimäki, Heikki Joensuu, Petri Bono, Pipsa Saharinen

Get full text

Transcript analysis of commercial prostate cancer risk stratification panels in hard-to-predict grade group 2-4 prostate cancers. by Lehto, T-PK, Stürenberg, C, Malén, A, Erickson, AM, Koistinen, H, Mills, IG, Rannikko, A, Mirtti, T

AI Model for Prostate Biopsies Predicts Cancer Survival by Kevin Sandeman, Sami Blom, Ville Koponen, Anniina Manninen, Juuso Juhila, Antti Rannikko, Tuomas Ropponen, Tuomas Mirtti

Get full text

Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis by Lehto, T-PK, Pylväläinen, J, Sandeman, K, Kenttämies, A, Nordling, S, Mills, IG, Tang, J, Mirtti, T, Rannikko, A

Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression by Maija Puhka, Lisse Thierens, Daniel Nicorici, Tarja Forsman, Tuomas Mirtti, Taija af Hällström, Elina Serkkola, Antti Rannikko

Get full text

The tumor and plasma cytokine profiles of renal cell carcinoma patients by Moon Hee Lee, Essi Laajala, Anna Kreutzman, Petrus Järvinen, Harry Nísen, Tuomas Mirtti, Maija Hollmén, Satu Mustjoki

Get full text

Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer. by Minna M Boström, Heikki Irjala, Tuomas Mirtti, Pekka Taimen, Tommi Kauko, Annika Ålgars, Sirpa Jalkanen, Peter J Boström

Get full text

High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer. by Paula Vainio, John-Patrick Mpindi, Pekka Kohonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin

Get full text

Engineering the future of 3D pathology by Liu, JT, Chow, SS, Colling, R, Downes, MR, Farré, X, Humphrey, P, Janowczyk, A, Mirtti, T, Verrill, C, Zlobec, I, True, LD

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma by Moon Hee Lee, Petrus Järvinen, Harry Nísen, Oscar Brück, Mette Ilander, Ilona Uski, Jason Theodoropoulos, Matti Kankainen, Tuomas Mirtti, Satu Mustjoki, Anna Kreutzman

Get full text

Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer by Eduard Chelebian, Christophe Avenel, Kimmo Kartasalo, Maja Marklund, Anna Tanoglidi, Tuomas Mirtti, Richard Colling, Andrew Erickson, Alastair D. Lamb, Joakim Lundeberg, Carolina Wählby

Get full text

Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma by Lassi Luomala, Kalle Mattila, Paula Vainio, Harry Nisén, Teijo Pellinen, Jouni Lohi, Teemu D. Laajala, Petrus Järvinen, Anna‐Riina Koskenniemi, Panu Jaakkola, Tuomas Mirtti

Get full text

Phosphorylation of PACSIN2 at S313 Regulates Podocyte Architecture in Coordination with N-WASP by Rim Bouslama, Vincent Dumont, Sonja Lindfors, Lassi Paavolainen, Jukka Tienari, Harry Nisen, Tuomas Mirtti, Moin A. Saleem, Daniel Gordin, Per-Henrik Groop, Shiro Suetsugu, Sanna Lehtonen

Get full text